[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Indexing and Abstracting::
Editorial Policies::
For Authors::
For Reviewers::
Registration::
Contact us::
Publication Ethics::
Ethical Policies::
Data Sharing Policy::
Peer Review Process::
Articles in Press::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 4, Issue 2 (10-2026) ::
injbir 2026, 4(2): 137-151 Back to browse issues page
A Network Biology Approach to Investigating Multiple Drug Resistance (MDR)
S.M.E. Kamrani * , F. Hadizadeh
Department of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
Abstract:   (8 Views)
Cancer is one of the leading causes of death worldwide in the 21st century. Several therapeutic strategies, including chemotherapy, radiotherapy, and immunotherapy, have been developed for cancer treatment. However, one of the major causes of treatment failure is the development of multiple drug resistance (MDR). Several mechanisms have been implicated in MDR, including alterations in metabolic pathways, overexpression of ATP-binding cassette (ABC) transporters, and other molecular alterations.
In this study, we analyzed microarray datasets comparing drug-resistant cancer cells with drug-sensitive counterparts to identify differentially expressed genes (DEGs). Protein–protein interaction (PPI) networks were subsequently constructed and analyzed using the STRING database. Based on topological network parameters, ten hub genes were identified, and their associated biological pathways were investigated using the Kyoto Encyclopedia of Genes and Genomes (KEGG) database. Finally, Venn diagram analysis was performed to identify common upregulated and downregulated genes across the analyzed datasets that may represent potential therapeutic targets.
Our analysis revealed that ABCB1, a key transporter involved in MDR, interacts with several genes, including FN1, MMP2, KDR, and members of the SLC gene family. Furthermore, P3H2, RPH3AL, NCF1, and NCF2 were consistently identified as commonly upregulated genes across the three analyzed datasets. These findings provide insights into the molecular mechanisms underlying MDR and may contribute to the identification of potential biomarkers and therapeutic targets for overcoming drug resistance in cancer.
Keywords: Multiple drug resistance (MDR), Network biology, Protein–protein interaction (PPI), Differentially expressed genes (DEGs), Hub genes, ABCB1, Bioinformatics
Full-Text [PDF 2279 kb]   (4 Downloads)    
Type of Study: Research | Subject: Special
Received: 2026/06/27 | Accepted: 2026/10/2 | Published: 2026/10/2
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kamrani S, Hadizadeh F. A Network Biology Approach to Investigating Multiple Drug Resistance (MDR). injbir 2026; 4 (2) :137-151
URL: http://injbir.com/article-1-93-en.html


Volume 4, Issue 2 (10-2026) Back to browse issues page
International Journal of Biological Reports International Journal of Biological Reports
Persian site map - English site map - Created in 0.15 seconds with 37 queries by YEKTAWEB 4758